A Clinical Study on Efficacy And Safety of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression A Multicenter, Randomized, Double-Blind, Parallel Controlled Study
Phase of Trial: Phase II/III
Latest Information Update: 22 Oct 2014
At a glance
- Drugs Trazodone (Primary)
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Lees Pharmaceutical Holdings
- 02 Oct 2013 Status changed from active, no longer recruiting to completed according to a Lee's Pharmaceutical Holdings media release.
- 02 Oct 2013 Primary endpoint 'Change in Hamilton Depression Rating Scale-17 score' has been met, according to a Lee's Pharmaceutical Holdings media release.
- 01 Oct 2013 Primary endpoint results have been published in a Pharmaceutical Holdings media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History